TOWA PHARMACEUTICAL CO., LTD.

4553・Prime Market・Pharmaceuticals

Official website

TOWA PHARMACEUTICAL CO., LTD.

4553・Prime Market・Pharmaceuticals

Official website

TOWA PHARMACEUTICAL CO., LTD.4553

Reference Indicators

Market Cap

2,195¥100M

P/E (Forecast)

—

P/B

1.2x

Dividend Yield (Forecast)

2.00%

ROE

3.0%

EV/EBITDA

8.4x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	165,615	208,859	227,934	259,594	273,710
Cost of Sales	95,429	136,145	146,551	164,865	174,606
Gross Profit	70,185	72,713	81,383	94,729	99,104
SG&A Expenses	50,980	67,199	63,735	71,486	76,001
Operating Income	19,205	5,514	17,647	23,242	23,102
Non-operating Income	4,546	2,889	8,111	4,921	7,472
Non-operating Expenses	1,011	3,262	1,282	2,011	2,495
Ordinary Income	22,739	5,141	24,477	26,152	28,079
Extraordinary Income	123	18	313	275	9
Extraordinary Losses	616	554	331	96	14,923
Pre-tax Income	22,246	4,605	24,459	26,330	13,165
Income Taxes	6,331	2,404	8,286	7,343	7,914
Net Income	15,914	2,201	16,173	18,986	5,250
EBITDA	30,159	24,923	35,535	43,341	45,939
Gross Margin	42.4%	34.8%	35.7%	36.5%	36.2%
Operating Margin	11.6%	2.6%	7.7%	9.0%	8.4%
ROA	4.8%	0.6%	3.8%	4.0%	1.1%
ROE	12.8%	1.6%	11.0%	11.6%	3.0%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
国内	216,976	27,097	12.5%
海外	56,734	458	0.8%
日本	0	0	0.0%